![Adora Ndu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adora Ndu
Direktor/Vorstandsmitglied bei
DBV TECHNOLOGIES
Vermögen: 719 943 $ am 31.05.2026
Profil
Dr. Adora Ndu ist VP-World Wide Research & Development bei BioMarin Pharmaceutical, Inc. Sie ist Mitglied des Board of Directors bei DBV Technologies SA. Dr. Ndu war zuvor als Mitglied der University of Maryland tätig. Sie erhielt ihren Abschluss an der University of Maryland Francis King Carey School of Law und einen Doktortitel am Howard University College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2026 | 32’908 ( 0.02% ) | 712 787 $ | 31.05.2026 | |
| 15.04.2026 | 1’825 ( 0% ) | 7 156 $ | 31.05.2026 |
Aktive Positionen von Adora Ndu
| Unternehmen | Position | Beginn |
|---|---|---|
| DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 19.05.2021 |
| BRIDGEBIO PHARMA, INC. | General Counsel | 01.01.2022 |
| ACADIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 10.10.2022 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Adora Ndu
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Adora Ndu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The University of Maryland Francis King Carey School of Law
 The University of Maryland Francis King Carey School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
 Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
